Dottikon ES Holding - Public Comps and Valuation Multiples

Dottikon ES Holding Overview

About Dottikon ES Holding

Dottikon ES Holding AG manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients for the chemical and pharmaceutical industry.

Founded

1913

HQ

Employees

860

Website

dottikon.com

Sectors

Chemicals
Biopharmaceuticals
BioTech

Financials

Last FY Revenue $481M

Last FY EBITDA $181M

EV

$5.2B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Dottikon ES Holding Financials

See Dottikon ES Holding valuation multiples based on analyst estimates

Dottikon ES Holding P&L

In the most recent fiscal year, Dottikon ES Holding reported revenue of $481M and EBITDA of $181M.

Dottikon ES Holding expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Dottikon ES Holding valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$481M	XXX	XXX	XXX
Gross Profit	XXX	$324M	XXX	XXX	XXX
Gross Margin	XXX	67%	XXX	XXX	XXX
EBITDA	XXX	$181M	XXX	XXX	XXX
EBITDA Margin	XXX	38%	XXX	XXX	XXX
EBIT	XXX	$149M	XXX	XXX	XXX
EBIT Margin	XXX	31%	XXX	XXX	XXX
Net Profit	XXX	$132M	XXX	XXX	XXX
Net Margin	XXX	27%	XXX	XXX	XXX
Net Debt	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Dottikon ES Holding including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Dottikon ES Holding achieved $481M in revenue and $181M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$481M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$324M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	67.4% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$181M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	37.6% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$149M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	31.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$132M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	27.4% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Dottikon ES Holding

This financial data table provides comprehensive performance metrics for Dottikon ES Holding, a company based in Switzerland. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Dottikon ES Holding reported $481M in total revenue.
Fiscal year EBITDA was $181M.
The company maintained a gross profit margin of 67.4% in the most recent fiscal year.
EBITDA margin for the fiscal year was 37.6%.
Net profit margin reached 27.4% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Dottikon ES Holding. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Dottikon ES Holding Stock Performance

Dottikon ES Holding has current market cap of CHF 4.2B (or $5.2B), and EV of CHF 4.1B (or $5.2B).

Market Cap Evolution

Dottikon ES Holding Stock Data

As of October 3, 2025, Dottikon ES Holding's stock price is CHF 304 (or $380).

See Dottikon ES Holding trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$5.2B	$5.2B	XXX	XXX	XXX	XXX	$5.96

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Dottikon ES Holding Valuation Multiples

Dottikon ES Holding's trades at 11.2x EV/Revenue multiple, and 30.1x EV/EBITDA.

See valuation multiples for Dottikon ES Holding and 15K+ public comps

Dottikon ES Holding Financial Valuation Multiples

As of October 3, 2025, Dottikon ES Holding has market cap of $5.2B and EV of $5.2B.

Equity research analysts estimate Dottikon ES Holding's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Dottikon ES Holding's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$5.2B	XXX	$5.2B	XXX	XXX	XXX
EV (current)	$5.2B	XXX	$5.2B	XXX	XXX	XXX
EV/Revenue	n/a	XXX	11.2x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	30.1x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	36.9x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	42.3x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-109.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Dottikon ES Holding Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Dottikon ES Holding Margins & Growth Rates

Dottikon ES Holding's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.2M for the same period.

Dottikon ES Holding's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dottikon ES Holding's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Dottikon ES Holding and other 15K+ public comps

Dottikon ES Holding Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	37%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.6M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	36%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial